Boston Scientific Corp. has received 510(k) clearance from the U.S. Food and Drug Administration and CE Mark approval to market its WallFlex Fully Covered Esophageal Stent for the treatment of ...

To evaluate the safety of self-expanding esophageal stents in a population-based trial, and determine the influence of hospital procedural volume, age and sex on patient survival rate.